Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria B Grant

Showing results (11-20 of 238) with videos related to

Pageof 24
Sort By:
Diabetologia|February 12, 2022
Lipids, hyperreflective crystalline deposits and diabetic retinopathy: potential systemic and retinal-specific effect of lipid-lowering therapiesAlicia J Jenkins, Maria B Grant, Julia V Busik
Investigative Ophthalmology & Visual Science|December 24, 2010
Selective blockade of cytoskeletal actin remodeling reduces experimental choroidal neovascularizationSergio Caballero, Ru Yang, Maria B Grant, et al.
Cells|November 26, 2020
The Potential Role of Osteopontin and Furin in Worsening Disease Outcomes in COVID-19 Patients with Pre-Existing DiabetesYvonne Adu-Agyeiwaah, Maria B Grant, Alexander G Obukhov
Frontiers in Endocrinology|December 26, 2012
Inflammation in the pathogenesis of microvascular complications in diabetesDung V Nguyen, Lynn C Shaw, Maria B Grant
Expert Review of Endocrinology & Metabolism|May 17, 2013
Promise of endothelial progenitor cell for treatment of diabetic retinopathyAshay D Bhatwadekar, Lynn C Shaw, Maria B Grant
Frontiers in Endocrinology|February 2, 2026
Mondo family proteins in diabetesSandeep Kumar Barodia, Maria B Grant, Marina S Gorbatyuk
Expert Opinion on Drug Discovery|February 1, 2018
Models of retinal diseases and their applicability in drug discoveryGoldis Malek, Julia Busik, Maria B Grant, et al.
Current Diabetes Reports|May 26, 2011
Cell-based therapies for diabetic retinopathyLynn C Shaw, Matthew B Neu, Maria B Grant
The Journal of Clinical Investigation|January 26, 2008
Erythropoietin: when liability becomes asset in neurovascular repairMaria B Grant, Michael E Boulton, Alexander V Ljubimov
Diabetes|September 11, 2014
Combination therapies prevent the neuropathic, proinflammatory characteristics of bone marrow in streptozotocin-induced diabetic ratsJames M Dominguez, Mark A Yorek, Maria B Grant
Pageof 24

Showing results (11-20 of 238) with videos related to

Sort By:
Pageof 24
Diabetologia|February 12, 2022
Lipids, hyperreflective crystalline deposits and diabetic retinopathy: potential systemic and retinal-specific effect of lipid-lowering therapiesAlicia J Jenkins, Maria B Grant, Julia V Busik
Investigative Ophthalmology & Visual Science|December 24, 2010
Selective blockade of cytoskeletal actin remodeling reduces experimental choroidal neovascularizationSergio Caballero, Ru Yang, Maria B Grant, et al.
Cells|November 26, 2020
The Potential Role of Osteopontin and Furin in Worsening Disease Outcomes in COVID-19 Patients with Pre-Existing DiabetesYvonne Adu-Agyeiwaah, Maria B Grant, Alexander G Obukhov
Frontiers in Endocrinology|December 26, 2012
Inflammation in the pathogenesis of microvascular complications in diabetesDung V Nguyen, Lynn C Shaw, Maria B Grant
Expert Review of Endocrinology & Metabolism|May 17, 2013
Promise of endothelial progenitor cell for treatment of diabetic retinopathyAshay D Bhatwadekar, Lynn C Shaw, Maria B Grant
Frontiers in Endocrinology|February 2, 2026
Mondo family proteins in diabetesSandeep Kumar Barodia, Maria B Grant, Marina S Gorbatyuk
Expert Opinion on Drug Discovery|February 1, 2018
Models of retinal diseases and their applicability in drug discoveryGoldis Malek, Julia Busik, Maria B Grant, et al.
Current Diabetes Reports|May 26, 2011
Cell-based therapies for diabetic retinopathyLynn C Shaw, Matthew B Neu, Maria B Grant
The Journal of Clinical Investigation|January 26, 2008
Erythropoietin: when liability becomes asset in neurovascular repairMaria B Grant, Michael E Boulton, Alexander V Ljubimov
Diabetes|September 11, 2014
Combination therapies prevent the neuropathic, proinflammatory characteristics of bone marrow in streptozotocin-induced diabetic ratsJames M Dominguez, Mark A Yorek, Maria B Grant
Pageof 24